Back to Search
Start Over
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
- Authors :
- Externen Hematologie
MS Hematologie
Infection & Immunity
Regenerative Medicine and Stem Cells
Goldschmidt, H
Lokhorst, H M
Mai, E K
van der Holt, B
Blau, I W
Zweegman, S
Weisel, K C
Vellenga, E
Pfreundschuh, M
Kersten, M J
Scheid, C
Croockewit, S
Raymakers, R
Hose, D
Potamianou, A
Jauch, A
Hillengass, J
Stevens-Kroef, M
Raab, M S
Broijl, A
Lindemann, H W
Bos, G M J
Brossart, P
van Marwijk Kooy, M
Ypma, P
Duehrsen, U
Schaafsma, R M
Bertsch, U
Hielscher, T
Jarari, Le
Salwender, H J
Sonneveld, P
Externen Hematologie
MS Hematologie
Infection & Immunity
Regenerative Medicine and Stem Cells
Goldschmidt, H
Lokhorst, H M
Mai, E K
van der Holt, B
Blau, I W
Zweegman, S
Weisel, K C
Vellenga, E
Pfreundschuh, M
Kersten, M J
Scheid, C
Croockewit, S
Raymakers, R
Hose, D
Potamianou, A
Jauch, A
Hillengass, J
Stevens-Kroef, M
Raab, M S
Broijl, A
Lindemann, H W
Bos, G M J
Brossart, P
van Marwijk Kooy, M
Ypma, P
Duehrsen, U
Schaafsma, R M
Bertsch, U
Hielscher, T
Jarari, Le
Salwender, H J
Sonneveld, P
- Publication Year :
- 2018
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1400044382
- Document Type :
- Electronic Resource